Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;31(10):1009-14.
doi: 10.1089/AID.2015.0111. Epub 2015 Aug 26.

Using Lopinavir Concentrations in Hair Samples to Assess Treatment Outcomes on Second-Line Regimens Among Asian Children

Affiliations

Using Lopinavir Concentrations in Hair Samples to Assess Treatment Outcomes on Second-Line Regimens Among Asian Children

Wasana Prasitsuebsai et al. AIDS Res Hum Retroviruses. 2015 Oct.

Abstract

We conducted a prospective monitoring study to determine whether antiretroviral (ARV) levels in hair of Asian children on second-line protease inhibitor-based ARV therapy (ART) are associated with virologic failure (VF), compared to plasma drug levels and self-reported adherence. HIV-infected Asian children on second-line ART regimens were enrolled into a longitudinal cohort. Traditional adherence measures, plasma, and hair samples were collected 24 weeks after study enrollment. Hair ARV levels were determined via liquid chromatography/tandem mass spectrometry. Among 149 children on lopinavir/ritonavir-based regimens, 47% were female; the median [interquartile range (IQR)] age was 10.3 (7.9-13.3) years. The median CD4% was 26% (IQR 21.7-32.1%) and the median CD4 cell count 754 (IQR 596-1,013) cells/mm(3). The median duration of lopinavir-based ART prior to week 24 of the study was 2.9 (IQR 1.6-4.2) years. Adherence was >95% in 91% (135/148) by visual analogue scale and 89% (129/145) by pill count. The median lopinavir hair concentrations were 5.43 (IQR 3.21-9.01) ng/mg in children with HIV RNA >1,000 copies/ml and 9.96 (IQR 6.51-12.31) ng/mg in children with HIV RNA <1,000 copies/ml (p = 0.003). Plasma trough and lopinavir hair concentrations were not statistically significantly correlated (Pearson's correlation coefficient 0.20; p = 0.13). Increasing lopinavir hair concentrations in quartiles were strongly associated with virologic success (odds ratios ≥4.0, overall p = 0.02), while self-reported adherence, pill count, and plasma lopinavir levels were not. Based on this first report of hair ARV concentrations and virologic outcomes in children, ARV hair concentrations, representing longer-term adherence, may be useful to identify children at risk for VF.

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.
Lopinavir hair concentrations by virologic suppression category. Lopinavir (LPV) hair concentrations (ng/mg of hair) in children who had viral load (VL) ≥1,000 (left) and <1,000 copies/ml (right). The box shows the interquartile range (IQR) and the white line in the center shows the median. Whiskers show the lowest and highest points within 1.5 times the IQR.

Similar articles

Cited by

References

    1. Chavanet P, Lopez J, Grappin M, et al. : Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 1994;8(7):945–950 - PubMed
    1. Pittet D, Monod M, Suter P, Frenk E, and Auckenthaler R: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220(6):751–758 - PMC - PubMed
    1. Berg KM. and Arnsten JH: Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr 2006;43(Suppl 1):S79–87 - PMC - PubMed
    1. Beumer JH, Bosman IJ, and Maes RA: Hair as a biological specimen for therapeutic drug monitoring. Int J Clin Pract 2001;55(6):353–357 - PubMed
    1. Hegstad S, Khiabani HZ, Kristoffersen L, et al. : Drug screening of hair by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2008;32(5):364–372 - PubMed

Publication types

MeSH terms